Results 1 to 10 of about 38,782 (264)

DLCO versus DLCO/VA as predictors of pulmonary gas exchange [PDF]

open access: bronzeRespiratory Medicine, 2007
The diffusing capacity of the lung is usually reported as both the diffusing capacity (DLCO) and the diffusing capacity divided by the alveolar volume (DLCO/VA). However, it is unclear which measure to use when interpreting pulmonary gas exchange. We therefore conducted this study to determine whether the DLCO or the DLCO/VA is a better predictor of ...
Peter W. Callas   +2 more
semanticscholar   +5 more sources

Relevance of partitioning DLCO to detect pulmonary hypertension in systemic sclerosis. [PDF]

open access: yesPLoS ONE, 2013
We investigated whether partitioning DLCO into membrane conductance for CO (DmCO) and pulmonary capillary blood volume (Vcap) was helpful in suspecting precapillary pulmonary (arterial) hypertension (P(A)H) in systemic sclerosis (SSc) patients with or ...
Nadia Sivova   +16 more
doaj   +7 more sources

Relationship between diffusion capacity and small airway abnormality in COPDGene [PDF]

open access: yesRespiratory Research, 2019
Impaired single breath carbon monoxide diffusing capacity (DLCO) is associated with emphysema. Small airways disease (SAD) may be a precursor lesion to emphysema, but the relationship between SAD and DLCO is undescribed. We hypothesized that in mild COPD,
Rachel N. Criner   +12 more
doaj   +3 more sources

The diffusing capacity of the lungs for carbon monoxide - an independent predictor of interstitial lung disease in patients with rheumatoid arthritis - results of a prospective study [PDF]

open access: yesRomanian Journal of Rheumatology, 2023
Background. The diffusing capacity of the lungs for carbon monoxide (DLCO) represents the most sensitive independent factor for highlighting the interstitial lung disease associated with rheumatoid arthritis (RA-ILD).
Maria-Luciana Anton   +4 more
doaj   +1 more source

Role of single-breath diffusing capacity for carbon monoxide in patients with chronic obstructive pulmonary disease

open access: yesAl-Azhar Assiut Medical Journal, 2021
Background Chronic obstructive pulmonary disease (COPD) is a common, preventable, and treatable disease characterized by persistent respiratory symptoms and airflow limitation that is due to airway and/or alveolar abnormalities, usually caused by ...
Hamdy M Abd-Allah   +3 more
doaj   +1 more source

Tips for 6 Months After COVID-19 Pneumonia: Acute Inflammatory Parameters

open access: yesBagcilar Medical Bulletin, 2023
Objective:In our study, we aimed to investigate the long-term effects of the acute phase parameters of C-reactive protein, procalcitonin, D-dimer, lymphocyte, thrombocyte and ferritin on the respiratory function parameters in patients hospitalized due to
Engin Aynacı, Gökhan Karakurt
doaj   +1 more source

Respiratory disorders of post-COVID-19 syndrome

open access: yesТерапевтический архив, 2023
Aim. Assess the functional state of trespiratory system and effectiveness of therapeutic tactics for broncho-obstructive syndrome (BOS) in patients in the post-COVID period. Materials and methods.
Igor V. Leshchenko   +3 more
doaj   +1 more source

Predictors of fatigue severity in early systemic sclerosis: a prospective longitudinal study of the GENISOS cohort. [PDF]

open access: yes, 2011
ObjectivesLongitudinal studies examining the baseline predictors of fatigue in SSc have not been reported. Our objectives were to examine the course of fatigue severity over time and to identify baseline clinical, demographic, and psychosocial predictors
Assassi, Shervin   +10 more
core   +14 more sources

Association of abnormal pulmonary vasculature on CT scan for COVID-19 infection with decreased diffusion capacity in follow up: A retrospective cohort study

open access: yesPLoS ONE, 2021
Background Coronavirus Disease 2019 (COVID-19) is a respiratory viral illness causing pneumonia and systemic disease. Abnormalities in pulmonary function tests (PFT) after COVID-19 infection have been described.
Daniel Salerno   +10 more
doaj   +2 more sources

Isolated abnormal diffusing capacity for carbon monoxide (iso↓DLco) is associated with increased respiratory symptom burden in people with HIV infection.

open access: yesPLoS ONE, 2023
ObjectivesAn isolated reduction in the diffusing capacity for carbon monoxide (DLco; iso↓DLco) is one of the most common pulmonary function test (PFT) abnormalities in people living with HIV (PWH), but its clinical implications are incompletely ...
Katerina L Byanova   +17 more
doaj   +1 more source

Home - About - Disclaimer - Privacy